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Abstract
Aims/hypothesis The aim of our study was to examine the
associations between sedentary time (SED-time), time spent
in moderate-to-vigorous-intensity physical activity (MVPA),
total physical activity energy expenditure (PAEE) and cardio-
respiratory fitness with metabolic risk among individuals with
recently diagnosed type 2 diabetes.
Methods Individuals participating in the Anglo-Danish-Dutch
Study of Intensive Treatment in People with Screen Detected
Diabetes in Primary Care (ADDITION)-Plus trial underwent
measurement of SED-time, MVPA and PAEE using a com-
bined activity and movement sensor (n =394), and evaluation
of cardiorespiratory fitness (n =291) and anthropometric and
metabolic status. Clustered metabolic risk was calculated by
summing standardised values for waist circumference, triac-
ylglycerol, HbA1c, systolic blood pressure and the inverse of
HDL-cholesterol. Multivariate linear regression analyses were
used to quantify the associations between SED-time, MVPA,
PAEE and cardiorespiratory fitness with individual metabolic
risk factors and clustered metabolic risk.
Results Each additional 1 h of SED-time was positively associ-
ated with clustered metabolic risk, independently of sleep dura-
tion andMVPA (β=0.16 [95%CI 0.03, 0.29]). After accounting
for SED-time, MVPAwas associated with systolic blood pres-
sure (β=−2.07 [−4.03, −0.11]) but not with clustered metabolic
risk (β=0.01 [−0.28, 0.30]). PAEE and cardiorespiratory fitness
were significantly and independently inversely associated with
clustered metabolic risk (β=−0.03 [−0.05, −0.02] and β=−0.06
[−0.10, −0.03], respectively). Associations between SED-time
and metabolic risk were generally stronger in the low compared
with the high fitness group.
Conclusions/interpretation PAEE was inversely associated
with metabolic risk, whereas SED-time was positively asso-
ciated with metabolic risk. MVPA was not associated with
clustered metabolic risk after accounting for SED-time. En-
couraging this high-risk group to decrease SED-time, partic-
ularly those with low cardiorespiratory fitness, and increase
their overall physical activity may have beneficial effects on
disease progression and reduction of cardiovascular risk.
Trial registration : ISRCTN99175498
Keywords ADDITION-Plus . Cardiovascular risk . Cohort .
Physical activity . Sedentary . Type 2 diabetes
Abbreviations
ADDITION Anglo-Danish-Dutch Study of Intensive
Treatment in People with Screen Detected
Diabetes in Primary Care
CVD Cardiovascular disease
IQR Interquartile range
MET value Metabolic equivalent of task value
MVPA Moderate-to-vigorous-intensity physical
activity
Electronic supplementary material The online version of this article
(doi:10.1007/s00125-013-3069-8) contains peer-reviewed but unedited
supplementary material, which is available to authorised users.
A. J. M. Cooper : S. Brage :U. Ekelund :N. J. Wareham :
S. J. Griffin : R. K. Simmons (*)
MRC Epidemiology Unit, University of Cambridge, Institute of
Metabolic Science, Box 285, Addenbrooke’s Hospital, Hills Road,
Cambridge CB2 0QQ, UK
e-mail: Rebecca.simmons@mrc-epid.cam.ac.uk
U. Ekelund
Department of Sport Medicine, Norwegian School of Sport Sciences,
Ullevål Stadion, Oslo, Norway
S. J. Griffin
Primary Care Unit, Institute of Public Health, University of
Cambridge, Cambridge, UK
Diabetologia (2014) 57:73–82
DOI 10.1007/s00125-013-3069-8
PA Physical activity
PAEE Physical activity energy expenditure
RMR Resting metabolic rate
SED-time Sedentary time
zMS Standardised clustered metabolic risk score
Introduction
Physical inactivity is an important modifiable lifestyle risk
factor associated with hyperglycaemia, hypertension,
dyslipidaemia and the risk of developing cardiovascular dis-
ease (CVD) in both healthy individuals and those with type 2
diabetes [1–5]. Despite the clear health benefits of physical
activity (PA), however, individuals with type 2 diabetes gen-
erally have low levels of PA [6, 7] and have difficulty
maintaining the required level necessary for improving meta-
bolic health [8]. Emerging evidence suggests that targeting
sedentary time (SED-time) may represent an additional ap-
proach to reducing metabolic risk in apparently healthy pop-
ulations [9–11]. The assessment of PA and SED-time in these
studies, however, has typically been derived from self-report
measures. The imprecision and bias associated with self-
report measures means that their ability to accurately assess
total activity, as well as PA intensity and SED-time, is limited.
The single study using an objective measure of PA in individ-
uals with type 2 diabetes showed that SED-time was positive-
ly associated with metabolic risk, whereas moderate-to-
vigorous-intensity physical activity (MVPA) was only weakly
inversely associated with risk [12]. Given the limited amount
of time spent in MVPA in this population, and the large
amount of SED-time, targeting reductions in SED-time by
increasing overall physical activity energy expenditure
(PAEE), independently of MVPA, may offer a more feasible
strategy to managing metabolic risk. Before advocating trials
aimed at reducing SED-time in this population, however, it is
important first to elucidate whether this association is inde-
pendent of sleep duration, which might confound the associ-
ation with metabolic risk [13]. As the association between
different dimensions of PA and metabolic risk may differ by
level of cardiorespiratory fitness [14], it is also important to
establish whether these associations are modified by cardio-
respiratory fitness.
Using data from the ADDITION-Plus trial of individuals
with type 2 diabetes, which included objective measures of PA
using a combined heart rate and movement sensor, we aimed
to: (1) examine the magnitude, direction and relative associa-
tions between SED-time, MVPA, PAEE and cardiorespiratory
fitness with metabolic risk; and (2) determine whether associ-
ations of SED-time, MVPA and PAEE differ by level of
cardiorespiratory fitness.
Methods
The design and rationale for the ADDITION-Plus study have
been reported previously [15]. In brief, ADDITION-Plus is a
randomised controlled trial nested within the intensive treat-
ment arm of the ADDITION-Cambridge study, which evaluat-
ed the efficacy of a facilitator-led, theory-based behaviour
change intervention for recently diagnosed type 2 diabetic
patients. Thirty-four general practices in East Anglia participat-
ed in the study. Eligible individuals were those aged 40–69 years
who had been diagnosed with type 2 diabetes following screen-
ing in the ADDITION study or clinically diagnosed during the
previous 3 years in participating general practice surgeries.
Exclusion criteria were women who were pregnant or lactating
or those with a likely survival prognosis of less than 1 year. Out
of 1,109 eligible individuals, 478 agreed to participate in
ADDITION-Plus and were individually randomised to receive
either intensive treatment alone (n =239) or intensive treatment
plus the facilitator-led individual behaviour change intervention
(n=239). The two trial arms were pooled and a cohort analysis
conducted. All participants gave written informed consent, and
the study was approved by the Eastern Multi-Centre Research
Ethics Committee (reference number 02/5/54). The trial is reg-
istered as ISRCTN99175498.
Assessment of PA, cardiorespiratory fitness, sleep duration
and metabolic risk factors Assessment of ADDITION-Plus
participants included physiological and anthropometric mea-
sures by trained staff following standard operating procedures,
venesection and completion of self-report questionnaires. PA
was assessed using a combined heart rate and movement
sensor (Actiheart; CamNtech, Cambridge, UK) worn contin-
uously for 4 days in 30 s resolution [16]. A graded treadmill
walk test was used to calibrate heart rate individually [17] and
to estimate cardiorespiratory fitness by extrapolation of the
heart rate/oxygen consumption relationship to age-predicted
maximal heart rate. For participants who did not complete an
individual calibration test (n =170), we used all valid calibra-
tion tests in the rest of the sample (n =308) to derive a group
calibration equation adjusted for age, sex, beta blocker
(yes=94, no=214) and sleeping heart rate for the translation
of heart rate into activity intensity. Heart rate data collected
during the free-living period were processed using noise clas-
sification followed by Gaussian robust regression [18], and
average activity intensity (J min−1 kg−1) was estimated using a
branched equation framework [19]. Resulting time-series data
were summarised into PAEE (kJ kg−1 day−1), SED-time and
MVPA (min/day), whilst minimising diurnal information bias
caused by non-wear periods (segments of non-physiological
data). Cardiorespiratory fitness (V

O2max:pred ) was assessed for
291 participants (196 men and 95 women) using extrapolation
of heart rate response to a submaximal ramped exercise test to
age-predicted maximum heart rate (208–0.7×age), as
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described elsewhere [17]. SED-time was defined as a meta-
bolic equivalent of task value (MET value) of <1.5, in accor-
dance with current convention [20], and MVPA as ≥3.0 MET,
both primarily using the Oxford estimate of resting metabolic
rate (RMR) to define 1 MET [21], and secondarily using a
fixed value of 20.35 J ml O2×3.5 ml O2 min
−1 kg−1. Sensi-
tivity analyses were run to test the robustness of results with
regard toMET thresholds (<1.75MET vs <1.5MET for SED-
time, and ≥4.0 MET vs ≥3.0 MET for MVPA). We overlaid
self-reported sleep timings on the objective time-series data,
the appropriateness of which was verified by visual inspection
(see Methods, Covariate assessment, for a full explanation).
From these data, we calculated sleep duration and non-sleep
SED-time.
Blood pressure was calculated as the mean of three mea-
surements performed after 10 min of rest and with participants
seated with a cuff placed on the predominant arm at the level
of the heart, using an automatic sphygmomanometer (Omron
M4; Milton Keynes, UK). Body weight and height were
measured in light clothing and without shoes using a scale
(SECA; Birmingham, UK) and a fixed rigid stadiometer,
respectively. Waist circumference was calculated as the aver-
age of two measurements taken halfway between the lowest
point of the rib cage and the anterior superior iliac crest while
standing. HbA1c was measured in venous samples using an
ion-exchange high-performance liquid chromatography meth-
od (Tosoh Bioscience, Redditch, UK). Serum total cholester-
ol, HDL-cholesterol and triacylglycerol were measured using
enzymatic techniques (Dade Behring Dimension Analyzer;
Dade Behring, Newark, NJ, USA). Standardised self-
report questionnaires were used to collect information on
sociodemographic characteristics and sleep duration.
Covariate assessment Medication adherence was assessed by
the Medication Adherence Report Schedule (MARS) ques-
tionnaire [22]. Smoking status was assessed by questionnaire
with a yes/no answer to being a: current smoker, former
smoker or never smoker. Dietary intake was evaluated using
a validated food frequency questionnaire [23]. Occupational
socioeconomic class was evaluated by questionnaire and was
subsequently collapsed into three classes: (1) higher manage-
rial, administrative and professional occupations; (2) interme-
diate occupations; and (3) routine and manual occupations
[24]. Habitual bedtime and wake time were self-reported
for weekdays and weekends using the EPIC–Norfolk
Physical Activity Questionnaire (EPAQ2) [25]. Sleep duration
was calculated as (5/7×weekday sleep duration)+(2/7×
weekend sleep duration). We overlaid the self-reported sleep
timings on the time-series data from the combined heart rate
and movement sensor to visually identify participants who
had high motion/heart rate periods (which we identified as
being indistinguishable from time spent awake and in contrast
to combined heart rate and movement sensor data during time
spent sleeping) exceeding their self-reported bedtimes and/or
wake times by ≥30 min. Agreement between the self-reported
bedtimes and wake times with the objective time-series data
was assessed by two examiners independently for each par-
ticipant (A. J. M. Cooper and K. Westgate [Medical Research
Council Epidemiology Unit, Cambridge, UK]). The kappa
statistic for agreement between examiners was 0.77. Disagree-
ment between examiners was resolved by re-examination of
the data and discussion. In total, self-reported bedtimes and
wake times were deemed to be incompatible with the objec-
tive time-series data for 21 participants, who were excluded
from analyses.
Calculation of the clustered metabolic risk z score A summa-
ry score of clustered metabolic risk (zMS) was calculated by
summing standardised values for waist circumference, fasting
triacylglycerol, HbA1c and systolic blood pressure and the
inverse of HDL-cholesterol. Variables were standardised by
subtracting the sample mean from the individual mean and
dividing by the SD.
Complete data on objectively measured PA, metabolic risk
factors and potential confounding variables were available for
394 participants (n =291 for cardiorespiratory fitness).
Statistical analysis Descriptive characteristicswere summarised
separately for men and women using means with SDs, medians
with interquartile ranges (IQR) or frequencies. Wilcoxon
rank-sum tests, t tests or χ2 tests were used to examine
whether there were any differences in participant characteris-
tics between those with and those without missing data.
Fasting triacylglycerol values were log transformed (base e )
due to their non-normal distribution. Associations between SED-
time, MVPA, PAEE, V

O2max:pred and sleep duration were esti-
mated using Pearson correlation coefficients.
We used multivariate linear regression analyses to model
the associations between SED-time (h/day), MVPA (h/day),
PAEE (kJ kg−1 day−1) and V

O2max:pred (ml O2 kg
−1 min−1)
with individual subcomponents of the zMS (waist circumfer-
ence, fasting triacylglycerol, HbA1c, systolic blood pressure
and inverted HDL-cholesterol), and with the clustered
metabolic risk score as one variable after confirming that our
data met the assumptions underlying linear regression
(i.e. linearity, normality, homoscedasticity and absence of
multicolinearity). To compare directly the relative contribu-
tion of SED-time, MVPA, PAEE and V

O2max:pred we also
expressed these exposure variables in the same units (per SD
difference). Under the assumption that these variables are
measured with the same degree of measurement error, their
expression in standardised form allows direct comparisons of
the magnitude of association between measures and clustered
metabolic risk. All regression models are presented
unadjusted (crude) and adjusted for age, sex, intervention
group, occupational socioeconomic class, smoking status,
Diabetologia (2014) 57:73–82 75
sleep duration, total energy intake, percentage of energy from
fat, alcohol intake and waist circumference (except when
waist circumference or zMS were modelled as the outcome).
When the outcome of interest was blood pressure, HbA1c,
triacylglycerol or HDL-cholesterol, we additionally adjusted
for the use of antihypertensive, glucose-lowering or lipid-
lowering medication, respectively. For the zMS we adjusted
for the use of antihypertensive, glucose-lowering and lipid-
lowering medications. Finally, to examine the association
between SED-time (independently of MVPA) and MVPA
(independently of SED-time) with subcomponents of the
zMS and the score as one variable, we additionally adjusted
for MVPA and SED-time, respectively.
All data were analysed in continuous form, although some
data were categorised into tertiles for illustrative purposes.
Finally, we examined whether the associations with SED-
time, MVPA, PAEE and V

O2max:pred with zMS were modified
by age (<60 vs ≥60 years) and sex.We also examined whether
the associations of SED-time, MVPA and PAEE with meta-
bolic risk factors and clustered metabolic risk were modified
by cardiorespiratory fitness levels (continuous). In further
sensitivity analyses we examined whether our results would
have differed by excluding participants with fewer than 3 days
of combined heart rate and movement sensor data (n =21), or
by excluding participants who did not complete an individual
calibration test (n =103).
All statistical analyses were performed using Stata/SE 12.1
(StataCorp LP, College Station, TX, USA).
Results
Table 1 shows the anthropometric and metabolic characteris-
tics of participants with complete data at 1 year (n =394),
stratified by sex. The mean (SD) age of men and women
was 60.2 (7.4) and 60.5 (7.4) years, respectively. More men
than women met the inclusion criteria and agreed to partici-
pate in the study. Participants with missing data (n =84) had
similar baseline values for all anthropometric and metabolic
characteristics shown in Table 1 (data not shown). As
expected, men were taller and heavier than women, had a
larger waist circumference and reported consuming a greater
amount of alcohol. Men had higher systolic blood pressure
and triacylglycerol levels compared with women, whereas
women had higher total and HDL-cholesterol levels. Total
PAEE was higher among men than among women (37.6 vs
29.6 kJ kg−1 day−1, respectively; p <0.001) and men had
higher levels of cardiorespiratory fitness than women
(33.4 ml O2 kg
−1 min−1 vs 25.2 ml O2 kg
−1 min−1, respective-
ly; p <0.001). Men and women had similar amounts of SED-
time (9.1 vs 9.0 h/day, respectively; p =0.69), but men report-
ed spending fewer hours sleeping (8.1 vs 8.7 h/day,
respectively; p <0.001) and were more likely than women to
spend time in MVPA (p =0.007). SED-time was strongly
inversely correlated with time spent in MVPA (r =−0.60;
p <0.001) and with PAEE (r =−0.76; p <0.001). SED-time
was weakly inversely correlated with sleep duration (r=−0.28;
p<0.001). Cardiorespiratory fitness was moderately correlated
withMVPA (r=0.44; p<0.001) and PAEE (r=0.49; p<0.001),
and weakly inversely correlated with SED-time (r =−0.11;
p <0.001). MVPA was strongly correlated with PAEE
(r=0.90; p <0.001).
Table 2 shows crude and adjusted associations between
SED-time (h/day), MVPA (h/day), PAEE (kJ kg−1 day−1)
and V

O2max:pred with subcomponents of the zMS and the
clustered metabolic risk score as one variable. In adjusted
analyses, PAEE was inversely associated with waist circum-
ference (β=−0.27 cm; 95% CI −0.35, −0.20) and clustered
metabolic risk (β=−0.03; 95%CI −0.05, −0.02). Results were
similar for V

O2max:pred (Table 2). By contrast, SED-time was
positively associated with waist circumference (β=0.68 cm;
95% CI 0.01, 1.35), triacylglycerol levels (β=0.03; 95% CI
0.00, 0.06) and clustered metabolic risk (β=0.16; 95% CI
0.03, 0.29), and inversely associated with HDL-cholesterol
levels (β=−0.02; 95% CI −0.03, −0.001) in analyses adjusted
for time spent in MVPA. After accounting for SED-time, time
spent in MVPA only remained significantly inversely associ-
ated with systolic blood pressure (β=−2.07; 95% CI −4.03,
−0.11). The bottom row of Table 2 shows crude and adjusted
associations between standardised measures (SDs) of PAEE,
SED-time and MVPA with clustered metabolic risk. The
magnitude of the association between PAEE and metabolic
risk was similar to the magnitude between SED-time and
metabolic risk, although in the opposite direction, such that
each SD increase in PAEE was associated with a lower met-
abolic risk (β=−0.55; 95% CI −0.81, −0.28), whereas each
SD increase in SED-time was associated with a higher meta-
bolic risk (β=0.42; 95% CI 0.09, 0.75). Figure 1 highlights
the association of SED-time, MVPA, PAEE and V

O2max:pred
with metabolic risk after adjustment for potential confounding
factors. Table 1 in the electronic supplementary material
(ESM) shows the associations between metabolic risk vari-
ables with SED-time and MVPA using a fixed value of RMR
to define 1 MET; these results were largely similar to those
reported using individualised RMR, except for a stronger
inverse association between MVPA and waist circumference,
which remained significant after adjustment for SED-time.
There was no evidence to suggest that the associations
between SED-time, MVPA, PAEE and V

O2max:pred with
zMS were modified by either age (all p values ≥0.88) or sex
(all p values ≥0.32). Although the associations of SED-time,
MVPA and PAEE with metabolic risk factors and clustered
metabolic risk did not differ by level of cardiorespiratory
fitness (all p values for interaction ≥0.07, except for the
association between PAEE and HbA1c [p =0.03]), our results
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were suggestive of a stronger association between SED-time
and subcomponents of metabolic risk among individuals be-
low the median for cardiorespiratory fitness (ESM Table 2).
MVPA was strongly inversely associated with systolic blood
pressure among the least fit (β=−4.85 mmHg; 95% CI −9.22,
−0.48). The estimated β coefficients and 95% CIs were not
significantly different between models if we excluded partic-
ipants with fewer than 3 days of combined heart rate and
movement sensor data (n =21) (all p values ≥0.36) or we
excluded participants who did not complete an individual
calibration test (n =103) (all p values ≥0.46). Although our
results remained robust with regard to changes in MET
thresholds for SED-time, a threshold for MVPA of ≥4.0METs
was more strongly inversely associated (numerically larger
β coefficient), albeit non-significantly, with waist circumfer-
ence, systolic blood pressure and clustered metabolic
risk compared with an MVPA threshold of ≥3.0 METs
(ESM Table 3).
Discussion
In this cross-sectional study of individuals with recently
diagnosed type 2 diabetes, higher levels of SED-time were
Table 1 Anthropometric and metabolic characteristics of ADDITION-Plus participants (n=394), stratified by sex
Characteristic Men (n =250) Women (n=144) p value for difference
between groups
Age, years 60.2 (7.4) 60.5 (7.4) 0.71
Occupational socioeconomic class, % 0.01
Managerial 47.2 31.9
Intermediate 22.0 30.6
Routine and manual 30.8 37.5
Height, cm 174.9 (7.2) 161.4 (6.9) <0.001
Weight, kg 96.9 (16.7) 85.9 (17.7) <0.001
BMI, kg/m2 31.6 (5.1) 32.9 (6.0) 0.03
Waist circumference, cm 111.3 (12.5) 105.0 (13.0) <0.001
Systolic blood pressure, mmHg 132.0 (16.7) 125.9 (17.0) <0.001
Triacylglycerol, mmol/la 1.7 (1.2–2.3) 1.6 (1.1–2.1) 0.06
Total cholesterol, mmol/l 4.2 (0.9) 4.4 (0.8) 0.008
HDL-cholesterol, mmol/l 1.1 (0.3) 1.3 (0.3) <0.001
HbA1c, % 6.7 (1.0) 6.6 (0.8) 0.68
HbA1c, mmol/mol 49.7 48.6
On glucose-lowering medication, % 49.6 54.9 0.31
On antihypertensive medication, % 72.4 70.1 0.63
On lipid-lowering medication, % 74.0 79.9 0.19
Total energy intake, kJ/daya 7,272 (6,130, 8,489) 6,602 (5,711, 8,489) 0.06
Percentage of energy from fat, % 30.6 (5.8) 30.9 (5.7) 0.62
Alcohol intake, g/daya 6.0 (1.0, 15.0) 2.0 (0.0, 5.0) <0.001
PAEE, kJ kg-1 day-1 b 37.6 (18.2) 29.6 (13.5) <0.001
Average sleep duration, h/day 8.1 (1.1) 8.7 (0.9) <0.001
Duration SED-time, h/dayb,c 9.1 (2.7) 9.0 (2.4) 0.69
Duration SED-time, h/dayb,d 10.3 (2.6) 10.5 (2.2) 0.50
Duration MVPA, h/dayb,c 1.4 (1.2) 1.1 (0.9) 0.007
Duration MVPA, h/dayb,d 0.88 (0.92) 0.43 (0.48) <0.001
V

O2max:pred , ml O2 kg
−1 min−1a,e 33.4 (28.1, 37.4) 25.2 (20.2, 31.9) <0.001
Data are means (SD) unless stated otherwise
aMedian (IQR)
b Individually calibrated where available (n=291), otherwise group calibrated (n =103)
c 1 MET defined using individual estimate of RMR [21]
d 1 MET defined using 71.2 J min−1 kg−1
eV

O2max:pred available for 291 participants (196 men and 95 women)
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associated with higher levels of metabolic risk, indepen-
dently of measured confounders and time spent in
MVPA. In contrast, time spent in MVPA was not sig-
nificantly associated with any metabolic risk factor ex-
cept for systolic blood pressure and waist circumference
after accounting for measured confounders and SED-
time. Total PAEE and V

O2max:pred were inversely associated
with waist circumference and a lower metabolic risk pro-
file, independently of measured confounders. Associations
between SED-time and measures of metabolic risk were
stronger in those with low fitness levels compared with
those in the high fitness group, suggesting that higher
levels of cardiorespiratory fitness may provide some pro-
tection against the deleterious effects of SED-time. Our
findings suggest that decreasing the amount of SED-time
and increasing overall PA may have beneficial effects on
disease progression and cardiovascular risk in patients with
type 2 diabetes.
Our study exhibits several strengths, including the use of
standardised measures and objective measurement of PA and
SED-time. The few previous studies that have objectively
assessed SED-time and/or PA have used either heart rate
or movement sensing [12, 26–28]. Deriving PA from heart
rate measurements alone can lead to imprecision due to the
difficulty in distinguishing time spent resting from time
spent engaging in low levels of PA that do not result in
elevations in heart rate. By contrast, relying on movement
sensing alone is limited due to the fact that acceleration of
typically only one body segment is recorded, and as such
certain activities will not be registered (e.g. cycling). Using
a combined heart rate and movement sensor allowed us to
discriminate between both rest and low-intensity locomotor
activities across biomechanically different activities. This is
important in a study population that spends a considerable
amount of time sedentary and very little time in MVPA.
Our findings are unlikely to be biased as participants with
and without missing data were similar. Finally, by using
objective time-series data for sleep duration, verified by
overlaying self-reported sleep time, we were able to exam-
ine all associations independently of sleep, which cannot be
considered the same as SED-time in terms of metabolic
risk [29, 30].
Some potential limitations of our study merit discussion.
First, as this is a cross-sectional study we cannot infer the
direction or the causal nature of the associations. Nevertheless,
findings from animal models have shown that a lack of local
contractile muscle stimulation, such as when sedentary, can
adversely affect triacylglycerol, HDL-cholesterol and other
metabolic risk factors as a result of suppression of muscle
lipoprotein lipase stimulation [31]. Second, despite the tran-
sient increase in heart rate when changing posture from sitting
to standing [32, 33], it is difficult to accurately distinguish
between time spent sitting and time spent standing using the
combined heart rate and movement data acquired in this study,
and as such it is possible that time spent standing was
misclassified as SED-time and vice versa. Any potential
misclassification of standing time as SED-time, however,
would likely have led to attenuation of the associations with
SED-time. Similarly, the questionnaire used to collect data
on habitual bedtime and wake time in this study did not
include questions related to naps or an estimate of actual
sleep duration, which might have resulted in sleep time
being misclassified as SED-time and vice versa. Use of a
more precise measure of sleep-related variables, such as
polysomnography, might reduce misclassification, but these
measures are currently not feasible in epidemiological studies.
Third, beneficial associations of MVPA with metabolic risk
factors might have been missed as a result of the definition of
MVPA, as suggested by the stronger, albeit non-significant,
inverse associations with waist circumference, systolic blood
pressure and clustered metabolic risk when we used a more
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Fig. 1 Associations of SED-time, MVPA, PAEE and cardiorespiratory
fitness with clustered metabolic risk. Mean SED-time in the lower
(reference), middle and higher tertile groups was 6.4 (range 1.2–8.0),
9.1 (range 8.0–10.4) and 11.6 (range 10.4–16.4) h/day, respectively (a).
Mean time spent in MVPA in the lower, middle and higher tertile groups
was 0.4 (range 0.0–0.6), 1.0 (range 0.6–1.5) and 2.4 (range 1.5–6.1) h/day,
respectively (b). Mean PAEE in the lower, middle and higher tertile groups
was 18.9 (range 5.6–24.7), 31.2 (range 24.8–39.4) and 50.3 (range 39.6–98.8)
kJ kg−1 day−1, respectively (c ). Mean cardiorespiratory fitness in the
lower (reference), middle and higher tertile groups was 21.0 (range
11.3–26.9), 31.0 (range 27.1–34.6) and 38.7 (range 34.8–58.6)
ml O2 kg
−1 min−1, respectively (d). Data are the zMS for each group
(95% CI), adjusted for age, sex, intervention group, occupational socio-
economic class, smoking status, sleep duration, total energy intake,
percentage energy from fat, alcohol intake, and use of antihypertensive
drugs, glucose-lowering drugs and lipid-lowering drugs. SED-time is
additionally adjusted for MVPA, and MVPA is additionally adjusted for
SED-time. p values for trend across categories for SED-time (a), MVPA
(b), PAEE (c) and cardiorespiratory fitness (d) were p =0.04, p=0.72,
p <0.001 and p =0.001, respectively
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stringent cut point of ≥4.0 METs, as opposed to ≥3.0 METs.
Associations with MVPA were not materially different when
we used a fixed intensity threshold of 142.5 J min−1 kg−1
above rest (3 METs) to define MVPA, rather than an
individualised threshold, except for a stronger inverse associ-
ation with waist circumference, which remained after adjust-
ment for SED-time. Fourthly, cardiorespiratory fitness was not
measured directly with a maximal test but was assessed using
extrapolation of heart rate response to a submaximal ramped
exercise test to age-predicted maximum heart rate. Finally, we
cannot exclude the possibility of residual confounding or
confounding by unmeasured factors.
Previous cross-sectional and prospective studies have
shown beneficial associations between high levels of objec-
tively assessed total PAwith HDL-cholesterol and triacylglyc-
erol, insulin and glucose levels in healthy individuals, while
longer durations of SED-time have been adversely associated
with waist circumference, insulin levels, triacylglycerol levels
and overall metabolic risk [26, 28, 34–37]. Further, measures
of glucose homeostasis have also been shown to be detrimen-
tally associated with SED-time among individuals with newly
diagnosed type 2 diabetes [12]. However, when the associa-
tion between 6-month change in SED-time and metabolic risk
was examined prospectively, no association with glucose ho-
meostasis was observed [12]. Differences between cross-
sectional and prospective findings may be explained by the
fact that the sample size of existing prospective studies may be
inadequate to detect small but biologically important associa-
tions related to changes in these behaviours, especially given
the short duration of follow-up. Nevertheless, results of stud-
ies with objective measures of PAEE and SED-time are con-
sistent with those of prospective studies which have used self-
reported data and have shown that PA is a good predictor of
CVD morbidity and mortality [38–41] and that SED-time is
associated with an increased risk of CVD events [4, 9]. The
association between different dimensions of PA and metabolic
risk has been shown to differ by cardiorespiratory fitness in
healthy adults free from type 2 diabetes [14]. While our
findings suggest that reductions in SED-time may be particu-
larly beneficial among the least fit, they highlight the impor-
tance of reducing SED-time and increasing total PA for all
patients with type 2 diabetes. The present results extend
previous observations by using individually calibrated com-
bined heart rate and movement sensing, which has been
shown to have high validity for estimating PAEE in both
laboratory [42] and free-living conditions [43] and which
overcomes many of the limitations associated with either heart
rate or movement monitoring alone [16]. Further, we demon-
strate that the associations between PAEE and SED-time with
metabolic risk are independent of sleep duration.
It is important to consider the clinical implications of the
observed association between SED-time and the metabolic risk
factors. Each 1 h/day increase in SED-time was associated
with a 0.68 cm higher waist circumference, a 0.03 mmol/l
higher triacylglycerol level and a 0.02 mmol/l lower HDL-
cholesterol level. The difference in SED-time between the 25th
and 75th percentiles, however, was almost 4 h/day, which
suggests that if the association were causal then it is not
unreasonable to suggest that moving from the top to the bottom
quartile of SED-time could result in a reduction in waist
circumference of over 2.5 cm, a reduction in triacylglycerol
levels of 0.12 mmol/l and an increase in HDL-cholesterol by
0.08 mmol/l. In context, changes of this magnitude have each
been associated with a 3–5% reduction in CVD risk [44–46].
Our findings support the hypothesis that the biological
responses to SED-time likely influence metabolic risk through
pathways distinct from those which have been implicated for
MVPA [47, 48]. Our data also suggest that while adults with
type 2 diabetes may gain additional health benefits from
participating in MVPA, reducing SED-time and increasing
overall activity, even if it is less than the recommended guide-
lines [49] it will result in important health benefits. Thus, our
findings are consistent with the recommendations of the
American Diabetes Association [1], highlighting the impor-
tance not only of MVPA but also of increasing overall PA at
the expense of SED-time. These findings highlight the need to
develop interventions to reduce SED-time that might be in-
corporated into educational programmes for newly diagnosed
patients. This will require better information about determi-
nants of SED-time in this group, but in the meantime simple
and cheap approaches such as the provision of pedometers
might be recommended [50].
In conclusion, total PAEE, but not MVPA, was associated
with improved metabolic risk status in this cohort of recently
diagnosed type 2 diabetic patients. Individuals with higher levels
of SED-time had higher levels of metabolic risk, and this was
particularly noticeable among those with low cardiorespiratory
fitness levels. Encouraging this high-risk group to decrease their
SED-time by increasing overall PA may have beneficial effects
on disease progression and reduction of CVD risk. Future
research is needed in order to establish the prospective associa-
tions between changes in PAEE, SED-time and time spent in
MVPAwith metabolic risk, as well as to establish the determi-
nants and maintenance of change in this population.
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